Extra length of stay and costs because of health care-associated infections at a German university hospital.
暂无分享,去创建一个
Stefan Hagel | Michael Hartmann | André Scherag | Florian Rissner | R. Baldessarini | A. Scherag | F. Brunkhorst | H. Arefian | S. Hagel | S. Heublein | Florian Rissner | M. Hartmann | Habibollah Arefian | Steffen Heublein | Frank Martin Brunkhorst | Ross J Baldessarini
[1] D. Pittet,et al. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.
[2] Martin Schumacher,et al. Estimating summary functionals in multistate models with an application to hospital infection data , 2011, Comput. Stat..
[3] M. Schumacher,et al. Use of Multistate Models to Assess Prolongation of Intensive Care Unit Stay Due to Nosocomial Infection , 2006, Infection Control & Hospital Epidemiology.
[4] K. McBride,et al. Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study , 2014, BMC Pulmonary Medicine.
[5] Nicholas Graves,et al. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] Deborah Braccia,et al. Systematic review of economic analyses of health care-associated infections. , 2005, American journal of infection control.
[7] Nicholas Graves,et al. Economics and Preventing Hospital-acquired Infection , 2004, Emerging infectious diseases.
[8] P. Gastmeier,et al. Nutzen eines krankenhausweiten Infektionspräventions-Programmes zur Reduktion nosokomialer Infektionen und assoziierter Sepsisfälle (ALERTS) – Methodik und Zwischenergebnisse , 2013, Deutsche Medizinische Wochenschrift.
[9] Margaret A Dudeck,et al. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.
[10] N. Graves,et al. The prolongation of length of stay because of Clostridium difficile infection. , 2014, American journal of infection control.
[11] Martin Schumacher,et al. Empirical Transition Matrix of Multi-State Models: The etm Package , 2011 .
[12] David Moher,et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[13] P. Gastmeier,et al. Nosocomial infection and antibiotic use: a second national prevalence study in Germany. , 2013, Deutsches Arzteblatt international.
[14] Stephan Harbarth,et al. Estimating the cost of health care-associated infections: mind your p's and q's. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] J. Schrenzel,et al. Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs. , 2013, The Journal of hospital infection.
[16] N. Graves,et al. Excess Length of Stay Due to Central Line–Associated Bloodstream Infection in Intensive Care Units in Argentina, Brazil, and Mexico , 2010, Infection Control & Hospital Epidemiology.
[17] M. Schrappe,et al. [How many nosocomial infections are avoidable?]. , 2010, Deutsche medizinische Wochenschrift.
[18] M. Schrappe,et al. Wie viele nosokomiale Infektionen sind vermeidbar? , 2010, Deutsche medizinische Wochenschrift.
[19] R. Scott,et al. The Direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention , 2009 .
[20] M. Schumacher,et al. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit , 1992, European Journal of Clinical Microbiology and Infectious Diseases.